The designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery
13-Mar-2018 – 3.93p – £30.7m – PER 15.3
Results For The 12 Months To End December 2017 – Revenues up by 44% to £8.75m (2016: £6.09m), Adjusted PBT of £1.10m (2017 reported: £0.54m, 2016: £0.28m), Adjusted EPS of 0.19 pence (2017 reported: 0.10 pence, 2016: 0.15 pence) with Net Debt at £0.73m (2016: Net Cash of £0.72m). Some Q1 headwinds (weather) but optimistic no FY impact.
Not overly convinced here and with Broker downgrades and a 6% Spread I will leave alone for now.
11-Sep-2018 – 3.4p – £26.0m – PER 17.3
Interim Results For The 6 Months To End June 2018 – Revenue up 52.4% to £5.28m (2017H1: £3.47m), primarily due to the acquisition of Elemental Healthcare, Reported PBT (after acquisition related amortisation costs and share based payment charges) of £0.09m, Adjusted EPS of 0.05p (2017H1: 0.06p) with Net cash at £0.02m (31 Dec 2017: net debt£0.73m).
I remain Neutral here for now.